Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Vincent, HA"'
Publikováno v:
Supportive Care in Cancer. 28:4963-4969
Patients with advanced cancer often experience symptoms including pain, nausea, anorexia, fatigue, and depression. High symptom burden can be alleviated by multidisciplinary palliative care (PC) teams practicing symptom-directed management. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::349169a291259495164565a089a8dd01
https://doi.org/10.1007/s00520-020-05330-2
https://doi.org/10.1007/s00520-020-05330-2
Autor:
Vincent Ha, Ani Nahapetian
Publikováno v:
Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering ISBN: 9783030955922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4736dc01a4409934c0e80618a4385e2e
https://doi.org/10.1007/978-3-030-95593-9_10
https://doi.org/10.1007/978-3-030-95593-9_10
Autor:
Grace G. Wong, Michael P. Chu, Vincent Ha, Carole R Chambers, Deonne Dersch-Mills, Sunita Ghosh, Michael B. Sawyer
Publikováno v:
Clinical Colorectal Cancer. 18:72-79
Background First-line adjuvant chemotherapy options for early-stage colorectal cancer (CRC) include CapeOx (capecitabine, intravenous oxaliplatin) and FOLFOX (intravenous 5-fluorouracil, leucovorin, oxaliplatin). Capecitabine is an oral prodrug analo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::841a8941f60d0acbbc47419ae93731c0
https://doi.org/10.1016/j.clcc.2018.11.001
https://doi.org/10.1016/j.clcc.2018.11.001
Autor:
Vincent Ha, Dean T. Eurich, Susie Youn, Michael McCall, Carole Chambers, Angela Chen, Michael B. Sawyer
Publikováno v:
Clinical nutrition (Edinburgh, Scotland). 40(8)
Summary Background Body composition is increasingly being studied as a method of predicting chemotherapy toxicity. Our study aimed to evaluate associations of body composition with treatment toxicity in a group of pancreatic cancer patients treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399c998f87f9a1900f5d70ec55387ff9
https://pubmed.ncbi.nlm.nih.gov/34358833
https://pubmed.ncbi.nlm.nih.gov/34358833
Autor:
Carole R Chambers, Vincent Ha, Michael McCall, Dean T. Eurich, Angela Chen, Susie Youn, Michael B. Sawyer
Publikováno v:
Cancer Research. 81:432-432
Introduction: Gemcitabine (GEM) plus nab-paclitaxel (nab) has been shown to improve overall survival (OS) compared to GEM monotherapy in patients with metastatic pancreatic cancer. However, GEM/nab is associated with increased toxicity. Our study eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa8854f9b0e5c2d628474e62185a1f58
https://doi.org/10.1158/1538-7445.am2021-432
https://doi.org/10.1158/1538-7445.am2021-432
Publikováno v:
Pharmacotherapy. 37(8)
Gilbert syndrome (GS) is a hereditary condition that affects ~10% of the population. It is characterized by intermittent, unconjugated hyperbilirubinemia in the absence of hepatocellular damage and hemolysis. Although GS is often described as a benig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56f29aa56c4d6ba0d303fcad9f35b9c
https://pubmed.ncbi.nlm.nih.gov/28494109
https://pubmed.ncbi.nlm.nih.gov/28494109
Autor:
Nikki Ryan, Catherine Leyshon, Sunita Ghosh, Carole R Chambers, Douglas A. Stewart, Vincent Ha
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 24(5)
Reversible late onset neutropenia associated with rituximab has been reported with incidence rates varying from 15 to 70% in B cell lymphoma patients receiving autologous stem cell transplantation. We conducted a retrospective descriptive study at on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b71053fde297040c094f4eb13de6388
https://pubmed.ncbi.nlm.nih.gov/28358279
https://pubmed.ncbi.nlm.nih.gov/28358279
Publikováno v:
Journal of Oncology Pharmacy Practice. 21:194-200
Introduction: Renal cell cancer is a chemotherapy-insensitive cancer treated by vascular endothelial growth factor receptor antagonists. Recently, a question has arisen on whether there is an interaction between tyrosine kinase inhibitors, such as su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8388603b3bcfa3b3ad537cc281fb171c
https://doi.org/10.1177/1078155214527145
https://doi.org/10.1177/1078155214527145
Publikováno v:
Journal of Medical Imaging and Radiation Sciences. 50:S7
Patients with advanced cancer often experience symptoms including pain, nausea, anorexia, fatigue, and depression. High symptom burden can be alleviated by multidisciplinary palliative care (PC) teams practicing symptom-directed management. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9405dbf2af703d9c73e7462880b076c1
https://doi.org/10.1016/j.jmir.2019.03.144
https://doi.org/10.1016/j.jmir.2019.03.144
Autor:
Deonne Dersch-Mills, Michael Patvin Chu, Carole R Chambers, Sunita Ghosh, Grace G. Wong, Vincent Ha, Michael B. Sawyer
Publikováno v:
Journal of Clinical Oncology. 36:3614-3614
621 Title: Effects of Proton Pump Inhibitors (PPIs) on FOLFOX and XELOX Regimens in Colorectal Cancer (CRC) Background: First-line adjuvant chemotherapy options for stage II-III CRC include XELOX (capecitabine (cape), oxaliplatin) and FOLFOX (oxalipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac72d303f76ab59888549425b18866b
https://doi.org/10.1200/jco.2018.36.15_suppl.3614
https://doi.org/10.1200/jco.2018.36.15_suppl.3614